Blended style of drug-induced liver injury (cholestasis and hepatitis) with bile duct destruction and moderate fibrosisThe FDA has issued warning letters to companies promoting unapproved products and solutions marketed as SARMs over time. The FDA has also pursued legal actions for distributors of those products. Make sure to do your research righ